145 related articles for article (PubMed ID: 38924104)
1. Ferroptosis defense mechanisms: The future and hope for treating osteosarcoma.
Ma Y; Cong L; Shen W; Yang C; Ye K
Cell Biochem Funct; 2024 Jun; 42(4):e4080. PubMed ID: 38924104
[TBL] [Abstract][Full Text] [Related]
2. Tumor-oriented and chemo-photothermal nanoplatform capable of sensitizing chemotherapy and ferroptosis against osteosarcoma metastasis.
Wu H; Li B; Shao J; Kong Q
Int J Biol Macromol; 2024 Jun; 269(Pt 2):132019. PubMed ID: 38729498
[TBL] [Abstract][Full Text] [Related]
3. Tirapazamine suppress osteosarcoma cells in part through SLC7A11 mediated ferroptosis.
Shi Y; Gong M; Deng Z; Liu H; Chang Y; Yang Z; Cai L
Biochem Biophys Res Commun; 2021 Aug; 567():118-124. PubMed ID: 34147710
[TBL] [Abstract][Full Text] [Related]
4. EF24 induces ferroptosis in osteosarcoma cells through HMOX1.
Lin H; Chen X; Zhang C; Yang T; Deng Z; Song Y; Huang L; Li F; Li Q; Lin S; Jin D
Biomed Pharmacother; 2021 Apr; 136():111202. PubMed ID: 33453607
[TBL] [Abstract][Full Text] [Related]
5. Present Advances and Future Perspectives of Molecular Targeted Therapy for Osteosarcoma.
Shaikh AB; Li F; Li M; He B; He X; Chen G; Guo B; Li D; Jiang F; Dang L; Zheng S; Liang C; Liu J; Lu C; Liu B; Lu J; Wang L; Lu A; Zhang G
Int J Mol Sci; 2016 Apr; 17(4):506. PubMed ID: 27058531
[TBL] [Abstract][Full Text] [Related]
6. Bavachin Induces Ferroptosis through the STAT3/P53/SLC7A11 Axis in Osteosarcoma Cells.
Luo Y; Gao X; Zou L; Lei M; Feng J; Hu Z
Oxid Med Cell Longev; 2021; 2021():1783485. PubMed ID: 34707773
[TBL] [Abstract][Full Text] [Related]
7. Single-Atom Cu Nanozyme-Loaded Bone Scaffolds for Ferroptosis-Synergized Mild Photothermal Therapy in Osteosarcoma Treatment.
Yan Z; Wu X; Tan W; Yan J; Zhou J; Chen S; Miao J; Cheng J; Shuai C; Deng Y
Adv Healthc Mater; 2024 Jun; 13(15):e2304595. PubMed ID: 38424663
[TBL] [Abstract][Full Text] [Related]
8. The canonical Wnt-beta-catenin pathway in development and chemotherapy of osteosarcoma.
Li C; Shi X; Zhou G; Liu X; Wu S; Zhao J
Front Biosci (Landmark Ed); 2013 Jun; 18(4):1384-91. PubMed ID: 23747891
[TBL] [Abstract][Full Text] [Related]
9. Research progress on the role of lncRNA, circular RNA, and microRNA networks in regulating ferroptosis in osteosarcoma.
Yan C; Dou Y; Xia R; Liu S; Fu J; Li D; Wang R; Tie F; Li L; Jin H; An F
Biomed Pharmacother; 2024 Jul; 176():116924. PubMed ID: 38876052
[TBL] [Abstract][Full Text] [Related]
10. Research Progress of Nanomaterials in Chemotherapy of Osteosarcoma.
Yu T; Cai Z; Chang X; Xing C; White S; Guo X; Jin J
Orthop Surg; 2023 Sep; 15(9):2244-2259. PubMed ID: 37403654
[TBL] [Abstract][Full Text] [Related]
11. Anti-Her2 affibody-decorated arsenene nanosheets induce ferroptosis through depleting intracellular GSH to overcome cisplatin resistance.
He P; Xu S; Miao Z; Que Y; Chen Y; Li S; Ma Q; Yang R; Wei W; Zha Z; Hu Y
J Nanobiotechnology; 2023 Jun; 21(1):203. PubMed ID: 37370105
[TBL] [Abstract][Full Text] [Related]
12. P-Glycoprotein Overexpression Is Associated With Cisplatin Resistance in Human Osteosarcoma.
He C; Sun Z; Hoffman RM; Yang Z; Jiang Y; Wang L; Hao Y
Anticancer Res; 2019 Apr; 39(4):1711-1718. PubMed ID: 30952710
[TBL] [Abstract][Full Text] [Related]
13. The role of programmed cell death in osteosarcoma: From pathogenesis to therapy.
Liu S; Liu C; Wang Y; Chen J; He Y; Hu K; Li T; Yang J; Peng J; Hao L
Cancer Med; 2024 May; 13(10):e7303. PubMed ID: 38800967
[TBL] [Abstract][Full Text] [Related]
14. The Anthelmintic Drug Niclosamide Inhibits the Proliferative Activity of Human Osteosarcoma Cells by Targeting Multiple Signal Pathways.
Liao Z; Nan G; Yan Z; Zeng L; Deng Y; Ye J; Zhang Z; Qiao M; Li R; Denduluri S; Wang J; Wei Q; Geng N; Zhao L; Lu S; Wang X; Zhou G; Luu HH; Haydon RC; He TC; Wang Z
Curr Cancer Drug Targets; 2015; 15(8):726-38. PubMed ID: 26118906
[TBL] [Abstract][Full Text] [Related]
15. Novel smoothened antagonists as anti-neoplastic agents for the treatment of osteosarcoma.
Bernardini G; Geminiani M; Gambassi S; Orlandini M; Petricci E; Marzocchi B; Laschi M; Taddei M; Manetti F; Santucci A
J Cell Physiol; 2018 Jun; 233(6):4961-4971. PubMed ID: 29215700
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA‑22 regulates autophagy and apoptosis in cisplatin resistance of osteosarcoma.
Meng CY; Zhao ZQ; Bai R; Zhao W; Wang YX; Sun L; Sun C; Feng W; Guo SB
Mol Med Rep; 2020 Nov; 22(5):3911-3921. PubMed ID: 33000186
[TBL] [Abstract][Full Text] [Related]
17. Notch pathway inhibition using DAPT, a γ-secretase inhibitor (GSI), enhances the antitumor effect of cisplatin in resistant osteosarcoma.
Dai G; Deng S; Guo W; Yu L; Yang J; Zhou S; Gao T
Mol Carcinog; 2019 Jan; 58(1):3-18. PubMed ID: 29964327
[TBL] [Abstract][Full Text] [Related]
18. Intrinsic resistance to chemotherapeutic agents in murine osteosarcoma cells.
Takeshita H; Kusuzaki K; Ashihara T; Gebhardt MC; Mankin HJ; Hirasawa Y
J Bone Joint Surg Am; 2000 Jul; 82-A(7):963-9. PubMed ID: 10901311
[TBL] [Abstract][Full Text] [Related]
19. Verification of Ferroptosis Subcluster-Associated Genes Related to Osteosarcoma and Exploration of Immune Targeted Therapy.
Jiang M; Jike Y; Gan F; Li J; Hu Y; Xie M; Liu K; Qin W; Bo Z
Oxid Med Cell Longev; 2022; 2022():9942014. PubMed ID: 36211822
[TBL] [Abstract][Full Text] [Related]
20. Apatinib inhibits migration and invasion as well as PD-L1 expression in osteosarcoma by targeting STAT3.
Zheng B; Ren T; Huang Y; Guo W
Biochem Biophys Res Commun; 2018 Jan; 495(2):1695-1701. PubMed ID: 29225166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
